Meet the inaugural holder of the Albert Boehringer (1st) Chair in Pharmacoepidemiology
$3 million gift creates Chair in pharmacoepidemiology
Robert Platt is Professor in the departments of Pediatrics and of Epidemiology, Biostatistics, and Occupational Health (EBOH) at McGill University, and Director of Graduate Programs in the department of EBOH. He holds the Albert Boehringer (1st) endowed chair in Pharmacoepidemiology.
Dr. Platt has been the leader of the Methods team of the Canadian Network for Observational Drug Effect Studies (DSEN-CNODES) since its inception. In this role he has led a methods research and training program for CNODES, and has participated as methods liaison (senior methods author) in several CNODES studies.
Dr. Platt received his PhD in Biostatistics from the University of Washington in 1996, and has been on faculty at McGill since then. His research interests are in statistical methods and applications for administrative-data pharmacoepidemiology and perinatal epidemiology, and in methods for causal inference from epidemiologic studies. His methodologic interests are in marginal structural models for analyses of large administrative-data cohorts, in particular with regard to specification and optimization of the propensity score and inverse probability weights.
Dr. Platt was the recipient of the Prix d’Excellence in 2005 from the Quebec Foundation for Research on Children’s Diseases, and holds a Chercheur-national (National research scholar) award from the Fonds de recherche en santé du Québec. He is principal investigator on a Foundation grant from the Canadian Institutes of Health Research and a Discovery grant Natural Sciences and Engineering Council of Canada, and co-investigator/subcontractor on multiple CIHR and NIH grants. He is Associate Editor of Statistics in Medicine, The International Journal of Biostatistics, American Journal of Epidemiology, and the Journal of Epidemiology and Community Health. Dr. Platt has published over 280 articles, one book, and several book chapters.
Research in Pharmacoepidemiology
Dr. Platt’s research in pharmacoepidemiology has two axes. His primary interest is statistical methods and applications for administrative-data pharmacoepidemiology, and in methods for causal inference from epidemiologic studies. His methodologic interests are in marginal structural models for analyses of big-data administrative-data cohorts, in particular with regard to specification and optimization of the propensity score and inverse probability weights. His other research axis links his expertise in pharmacoepidemiology with his ongoing program in perinatal epidemiology, to study the long-term effects of treatments mothers receive during pregnancy on both mothers and children. As the inaugural Albert Boehringer I Chair, Dr. Platt will continue his work in these areas and direct McGill’s new academic concentrations in pharmacoepidemiology.
Academic Options in Pharmacoepidemiology